Translational Medicine

Translational Medicine
Open Access

ISSN: 2161-1025

+44 1223 790975

Editorial Board

Min Li
Department of Cancer Research
University of Texas, USA

Martin J DSouza
Executive Editor
Mercer University, Atlanta, USA

Aamir Shahzad
Executive Editor
University of Vienna, Austria

Submit Manuscript

Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at

Table of Contents

About the Journal

Index Copernicus Value(ICV) 2015: 63.05

Translational Medicine is an international Open Access, peer-reviewed, academic journal providing an opportunity to share the information among the medical scientists and researchers.

This journal includes a wide range of Translational Research themes related cancer, Kidney, cardiovascular, Neuroscience, Gastrointestinal and liver diseases. It also includes Biomedical research, Genotyping, Regenerative medicine, Immuno therapies, Molecular targeted therapies, Molecular signaling and apoptosis, Translation research in Pharmacogenomics, Evidence based medicine and practice, Evidence based treatment, Pharmacokinetics, Pharmacodynamics, Drug discovery, Tissue injury and recovery, Proteomics, Vaccine delivery, Immunology-Vaccine Development, and Biotechnology in this discipline and creates a platform for the authors to contribute towards the journal.

Translational Medicine is a scholarly Open Access journal that aims to publish the most complete and reliable source of information on the discoveries and current developments as original articles, review articles, case reports, short communications, etc., making them available online to the researchers worldwide without any restrictions or any other subscriptions.

The journal is using Editorial manager System for manuscript submission, review and tracking. Editorial board members of the Translational Medicine Journal or outside experts review the manuscripts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.

Fast Editorial Review Process

Translational Medicine is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.


Articles published in Translational Medicine have been cited by esteemed scholars and scientists all around the world. Translational Medicine has got h-index 13 , which means every article in Translational Medicine has got 13 average citations.

Journal Highlights

Relevant Topics